Haemonetics Corp. engages in the development and distribution of hematology products and solutions. The company is headquartered in Boston, Massachusetts and currently employs 3,023 full-time employees. The firm is engaged in providing a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. The Company’s technology addresses various medical markets, including blood and plasma component collection, the surgical suite, and hospital transfusion services. The Company’s Plasma segment includes plasma collection devices and disposables, donor management software and supporting software solutions sold to plasma customers. Its Blood Center segment manufactures and provides customers with its full line of apheresis solutions for automated blood collection. The Company’s Hospital segment consists of Interventional Technologies, which includes Vascular Closure, Sensor Guided Technologies and Esophageal Protection products, and Blood Management Technologies, which includes Hemostasis Management, Cell Salvage and Transfusion Management products.
Follow-Up Questions
Haemonetics Corp (HAE) 的市盈率是多少？
Haemonetics Corp 的市盈率是 14.1217
Haemonetics Corp 的 CEO 是谁？
Mr. Christopher Simon 是 Haemonetics Corp 的 President，自 2016 加入公司。
HAE 股票的价格表现如何？
HAE 的当前价格为 $50.7，在上个交易日 increased 了 0.64%。
Haemonetics Corp 的主要业务主题或行业是什么？
Haemonetics Corp 属于 Health Care 行业，该板块是 Health Care
